Literature DB >> 9166781

Type II DNA topoisomerase from Saccharomyces cerevisiae is a stable dimer.

R B Tennyson1, J E Lindsley.   

Abstract

Type II DNA topoisomerases function as homodimeric enzymes in transiently cleaving double-stranded DNA to catalyze unlinking and unknotting reactions. The dimeric enzyme creates a DNA double-strand break by forming a covalent attachment between an active site tyrosine from each monomer and a 5'-phosphate from each strand of DNA. The dimer must be very stable to dissociation or subunit exchange when covalently attached to DNA to prevent directly or indirectly catalyzed rearrangements of the genome. Past studies have indicated conflicting results for the monomer-dimer stability of topoisomerase II in solution. Here, we report results from sedimentation equilibrium studies and two different subunit exchange assays indicating that purified Saccharomyces cerevisiae DNA topoisomerase II exists as a stable dimer in solution, with a Kd estimated to be < or = 10(-11) M. This high dimer stability is not detectably altered by a change of ionic strength or by the presence of ATP, ADP, or DNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9166781     DOI: 10.1021/bi970152f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  Preferential relaxation of positively supercoiled DNA by E. coli topoisomerase IV in single-molecule and ensemble measurements.

Authors:  N J Crisona; T R Strick; D Bensimon; V Croquette; N R Cozzarelli
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

2.  Analytical ultracentrifugation as a contemporary biomolecular research tool.

Authors:  J L Cole; J C Hansen
Journal:  J Biomol Tech       Date:  1999-12

Review 3.  Targeting DNA topoisomerase II in cancer chemotherapy.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

4.  Topoisomerase II drives DNA transport by hydrolyzing one ATP.

Authors:  C L Baird; T T Harkins; S K Morris; J E Lindsley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

Authors:  B D Lovett; L Lo Nigro; E F Rappaport; I A Blair; N Osheroff; N Zheng; M D Megonigal; W R Williams; P C Nowell; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

Review 6.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

7.  Regulation of Escherichia coli SOS mutagenesis by dimeric intrinsically disordered umuD gene products.

Authors:  S M Simon; F J R Sousa; R Mohana-Borges; G C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-23       Impact factor: 11.205

Review 8.  What makes a type IIA topoisomerase a gyrase or a Topo IV?

Authors:  Jana Hirsch; Dagmar Klostermeier
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

9.  Guiding strand passage: DNA-induced movement of the gyrase C-terminal domains defines an early step in the supercoiling cycle.

Authors:  Martin A Lanz; Dagmar Klostermeier
Journal:  Nucleic Acids Res       Date:  2011-08-31       Impact factor: 16.971

10.  C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.

Authors:  René M Linka; Andrew C G Porter; Arsen Volkov; Christian Mielke; Fritz Boege; Morten O Christensen
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.